Given that we have demonstrated previously that over-expression of Oxr1 in vivo can delay the neuroinflammatory response in a model of ALS [17], the relationship between glycolytic pathways and Oxr1 function in non-neuronal cells warrants further investigation in the future. The gene discussed is OXR1; the disease is amyotrophic lateral sclerosis.